Preceden

History of Synthetic Biology Timeline

(1970s - Present)

The history of synthetic biology traces the evolution of designing and constructing new biological parts, devices, and systems. Beginning with foundational discoveries in molecular biology and genetic engineering in the 1970s, the field expanded through landmark achievements such as the creation of synthetic gene circuits, the first synthetic genome, and CRISPR-based editing. Today, synthetic biology drives innovations in medicine, agriculture, biofuels, and materials science, blending engineering principles with biological science. Less

Go to: Timeline | Event List | Key Facts | Directory

Foundations and Early Science

Avery shows DNA is the material of genes

1944

Canadian-American scientist Oswald Avery demonstrated that DNA is the material of which genes and chromosomes are made, laying crucial groundwork for all later genetic engineering.

Image source: Oswald Avery

Avery shows DNA is the material of genes

Watson and Crick publish the structure of DNA

1953

Francis Crick and James Watson published the double-helix structure of DNA in Nature, revealing the molecular basis of heredity and enabling future efforts to read, write, and edit genetic material.

Image source: DNA

Watson and Crick publish the structure of DNA

Jacob and Monod postulate cellular regulation by molecular networks

1961

From their study of the lac operon in E. coli, Jacob and Monod postulated cellular regulation by molecular networks, providing a conceptual model for designing synthetic gene networks.

Image source: Lac operon

Jacob and Monod postulate cellular regulation by molecular networks

First PCR amplification using thermostable DNA polymerase

1988

The first DNA amplification by the polymerase chain reaction (PCR) using a thermostable DNA polymerase was published in Science by Mullis et al., giving scientists a powerful tool to amplify and manipulate DNA.

Image source: Polymerase chain reaction

First PCR amplification using thermostable DNA polymerase

First international conference Synthetic Biology 1.0 held at MIT

2004

The first international conference for synthetic biology, Synthetic Biology 1.0 (SB1.0), was held at MIT, bringing together an emerging community of engineers and biologists and helping define the field's agenda.

Image source: Synthetic biology

First international conference Synthetic Biology 1.0 held at MIT

Commercial gene synthesis reaches $1 per base pair

2007

It was reported that several companies were offering synthesis of genetic sequences up to 2000 bp long for about $1 per bp with turnaround times under two weeks, making custom DNA broadly accessible to researchers.

Image source: DNA synthesis

Commercial gene synthesis reaches $1 per base pair

Charpentier and Doudna program CRISPR-Cas9 for DNA targeting

2012

The Charpentier and Doudna labs published in Science the programming of CRISPR-Cas9 bacterial immunity for targeting DNA cleavage, revolutionizing genome editing and supercharging synthetic biology's toolkit.

Image source: CRISPR gene editing

Charpentier and Doudna program CRISPR-Cas9 for DNA targeting

Build-a-Cell open-source synthetic cell collaboration launched

2017

The international Build-a-Cell large-scale open-source research collaboration for the construction of synthetic living cells was started, followed by national organizations including FabriCell, MaxSynBio and BaSyC.

European synthetic cell efforts unified as SynCellEU initiative

2019

European synthetic cell efforts were unified in 2019 under the SynCellEU initiative, coordinating national programs across Europe toward constructing synthetic living cells.

Genome Synthesis

First molecular cloning of DNA in a plasmid

1973

The first molecular cloning and amplification of DNA in a plasmid was published in P.N.A.S., marking the birth of recombinant DNA technology and a foundational technique for synthetic biology.

Image source: Molecular cloning

First molecular cloning of DNA in a plasmid

Synthesis of Hepatitis C virus genome from oligonucleotides

2000

Researchers reported synthesis of the 9.6 kbp Hepatitis C virus genome from chemically synthesized 60 to 80-mers, an early demonstration that genomes could be assembled from synthetic fragments.

Image source: Hepatitis C

Synthesis of Hepatitis C virus genome from oligonucleotides

Poliovirus genome synthesized at Stony Brook University

2002

Researchers at Stony Brook University synthesized the 7741 bp poliovirus genome from its published sequence, producing the second synthetic genome over two years and sparking debates about dual-use research.

Image source: Poliovirus

Poliovirus genome synthesized at Stony Brook University

Bacteriophage Phi X 174 genome assembled

2003

The 5386 bp genome of the bacteriophage Phi X 174 was assembled from synthetic oligonucleotides in about two weeks, dramatically accelerating the pace of viral genome synthesis.

Image source: Phi X 174

Bacteriophage Phi X 174 genome assembled

J. Craig Venter Institute synthesizes larger bacterial genome work begins

2006

In 2006, the same team at the J. Craig Venter Institute continued advancing whole-genome synthesis, building on their rapid assembly of bacteriophage Phi X 174 toward ever-larger synthetic genomes.

Image source: Craig Venter

J. Craig Venter Institute synthesizes larger bacterial genome work begins

Venter team creates first synthetic bacterial chromosome and cell

2010

A completely synthetic bacterial chromosome was produced by Craig Venter and his team and introduced into genomically emptied bacterial host cells; researchers also published in Science the first synthetic bacterial genome, called M. mycoides JCVI-syn1.0.

Functional synthetic chromosome arms engineered in yeast

2011

Functional synthetic chromosome arms were engineered in yeast, extending synthetic genomics from bacteria to eukaryotic organisms and paving the way toward fully synthetic eukaryotic chromosomes.

Image source: Saccharomyces cerevisiae

Functional synthetic chromosome arms engineered in yeast

First living organism with artificial expanded DNA code

2014

The first living organism with an 'artificial' expanded DNA code was presented; the team used E. coli whose genetic alphabet had been expanded with synthetic nucleotides, demonstrating semi-synthetic life.

Record DNA data storage milestone reached

2014

Researchers achieved a landmark in DNA data storage: 5.3 Mb of data was stored, more than 1000 times greater than the previous largest amount of information kept in synthesized DNA.

Two artificial nucleotides introduced into bacterial DNA

May 2014

In May 2014, researchers announced they had successfully introduced two new artificial nucleotides into bacterial DNA, expanding life's chemical alphabet beyond natural bases A, T, C and G.

Image source: Nucleic acid analogue

Two artificial nucleotides introduced into bacterial DNA

First computer-designed bacterial genome Caulobacter ethensis-2.0

2019

Scientists at ETH Zurich reported the creation of the first bacterial genome, named Caulobacter ethensis-2.0, made entirely by a computer algorithm, although a related viable form of C. crescentus does not yet exist.

Image source: Caulobacter crescentus

First computer-designed bacterial genome Caulobacter ethensis-2.0

Synthetic E. coli variant with reduced 59-codon genome

May 2019

In May 2019, researchers reported the creation of a new synthetic form of viable life, a variant of Escherichia coli, by reducing the natural number of 64 codons in the bacterial genome to 59 codons to encode 20 amino acids.

Image source: Escherichia coli

Synthetic E. coli variant with reduced 59-codon genome

Synthetic Circuits and Engineering

First synthetic biological circuits reported in Nature

2000

Two papers in Nature reported synthetic biological circuits — a genetic toggle switch and a biological clock — created by combining genes within E. coli, launching modern synthetic biology as an engineering discipline.

Tom Knight invents BioBrick plasmids

2003

Tom Knight invented BioBrick plasmids, the most widely used standardized DNA parts, enabling modular assembly of genetic components and the rise of standardized biological design.

Image source: BioBrick

Tom Knight invents BioBrick plasmids

Light-sensing circuit developed in E. coli

2005

Researchers developed a light-sensing circuit in E. coli, showing that cells could be engineered to sense environmental signals like light and respond with programmed behaviors such as photograph-like images.

Universal logic evaluator demonstrated in human cells

2007

In human cells, research demonstrated a universal logic evaluator operating in mammalian cells, extending digital logic concepts from bacteria into medically relevant human cell types.

Image source: Logic gate

Universal logic evaluator demonstrated in human cells

Computer-engineering principles automate circuit design in bacteria

2016

Another group of researchers demonstrated that principles of computer engineering can be used to automate digital circuit design in bacterial cells, streamlining the design-build-test cycle of synthetic circuits.

BLADE system engineers digital computation in human cells

2017

Researchers demonstrated the Boolean logic and arithmetic through DNA excision (BLADE) system to engineer digital computation in human cells, advancing complex programmable behavior in mammalian cells.

Perceptron implemented in biological systems

2019

Researchers implemented a perceptron in biological systems, opening the way for machine learning capabilities inside living cells and merging artificial intelligence concepts with cellular engineering.

Image source: Perceptron

Perceptron implemented in biological systems

Applications and Medicine

Artemisinin precursor pathway engineered in E. coli

2003

Researchers engineered an artemisinin precursor pathway in E. coli, demonstrating that microbes could be reprogrammed to produce valuable drugs and inspiring a wave of metabolic engineering applications.

Image source: Artemisinin

Artemisinin precursor pathway engineered in E. coli

Synthetic circuit promotes bacterial invasion of tumour cells

2006

Researchers engineered a synthetic circuit that promotes bacterial invasion of tumour cells, an early example of using engineered microbes for targeted therapeutic purposes against cancer.

Image source: Cancer research

Synthetic circuit promotes bacterial invasion of tumour cells

Digital computation used to detect and kill cancer cells

2011

Researchers utilized the biological digital computation paradigm to demonstrate a proof-of-concept therapy that uses biological digital computation to detect and kill human cancer cells.

Image source: Cancer immunotherapy

Digital computation used to detect and kill cancer cells

More than 350 synthetic biology companies active worldwide

2016

By 2016, more than 350 companies across 40 countries were actively engaged in synthetic biology applications, with an estimated combined net worth of $3.9 billion in the global market.

First xenobot, a programmable AI-designed synthetic organism

2020

Scientists created the first xenobot, a programmable synthetic organism derived from frog cells and designed by artificial intelligence, opening a new frontier of living machines.

Image source: Xenobot

First xenobot, a programmable AI-designed synthetic organism

Xenobots shown able to self-replicate

2021

Scientists reported that xenobots are able to self-replicate by gathering loose cells in the environment and then forming new xenobots, a previously unseen mode of kinematic self-replication.

Synthetic coffee products approach commercialization

2021

Not all synthetic nutrition products are animal food products – as of 2021, there are also products of synthetic coffee that are reported to be close to commercialization, showcasing food applications of synthetic biology.

First clinical trial success for patient-cell bioprinted ear transplant

2022

In 2022, the first success of a clinical trial for a 3D bioprinted transplant made from a patient's own cells, an external ear to treat microtia, was reported, marking a milestone in regenerative medicine.

Image source: Microtia

First clinical trial success for patient-cell bioprinted ear transplant

First synthetically made human embryos derived from stem cells

2023

In 2023, researchers were able to create the first synthetically made human embryos derived from stem cells, raising profound scientific promise alongside significant ethical questions.

Image source: Embryo

First synthetically made human embryos derived from stem cells

Advances in RNA therapeutics improve synthetic biology safety and efficiency

2023

Advancements in RNA therapeutics, including vaccines, RNA circuits, and genetic modifications, improved safety and efficiency in synthetic biology, building on momentum from mRNA vaccine technologies.

Image source: MRNA vaccine

Advances in RNA therapeutics improve synthetic biology safety and efficiency

First clinical trial of engineered live yeast for C. difficile anticipated

2024

The first in-human clinical trial of engineered live yeast for the treatment of Clostridioides difficile infection is anticipated in 2024 and will be sponsored by the developer Fzata, Inc., representing a novel live biotherapeutic approach.

Image source: Clostridioides difficile infection

First clinical trial of engineered live yeast for C. difficile anticipated

Ethics, Safety and Society

DNA-synthesis companies publish industry oversight framework plan

2007

A group led by scientists from leading DNA-synthesis companies published a practical plan for developing an effective oversight framework for the DNA-synthesis industry, addressing biosecurity concerns proactively.

Paper identifies key safety, security and ethics issues

2007

A paper identified key issues in safety, security, ethics, and the science-society interface, defining public education and ongoing dialogue among scientists, businesses, government and ethicists as central priorities.

Alfred P. Sloan Foundation funds synthetic biology ethics work

Jan 2009

In January 2009, the Alfred P. Sloan Foundation supported efforts to examine the societal implications of synthetic biology, funding initiatives on governance and public engagement in the emerging field.

Image source: Alfred P. Sloan Foundation

Alfred P. Sloan Foundation funds synthetic biology ethics work

National Academies symposium on synthetic biology opportunities

Jul 9, 2009 - Jul 10, 2009

On July 9–10, 2009, the National Academies' Committee of Science, Technology & Law convened a symposium on Opportunities and Challenges in the Emerging Field of Synthetic Biology, gathering experts to assess the field's trajectory.

Image source: National Academy of Sciences

National Academies symposium on synthetic biology opportunities

SYNBIOSAFE documentary film released

Oct 2009

To communicate synthetic biology and its societal ramifications to a broader public, COSY and SYNBIOSAFE published SYNBIOSAFE, a 38-minute documentary film exploring the promises and risks of the field.

Image source: Synthetic biology

SYNBIOSAFE documentary film released

Presidential commission issues report on ethics of synthetic biology

Dec 2010

The Presidential Commission for the Study of Bioethical Issues issued its report New Directions: The Ethics of Synthetic Biology and Emerging Technologies, stating that while Venter's achievement marked a significant technical advance, it did not amount to the creation of life.

Manifesto The Principles for the Oversight of Synthetic Biology issued

Mar 13, 2012

Over 100 environmental and civil society groups, including Friends of the Earth, the International Center for Technology Assessment, and the ETC Group, issued the manifesto The Principles for the Oversight of Synthetic Biology calling for stronger regulation.

Key Facts

  1. In 1973, Herbert Boyer and Stanley Cohen created the first genetically modified organism by transferring DNA between bacteria, laying the groundwork for synthetic biology.
  2. In 2000, researchers Eric Wieschaus's colleagues James Collins and Tim Gardner built the first synthetic gene circuit, a 'toggle switch,' demonstrating that biological systems could be programmatically designed.
  3. In 2010, Craig Venter's team created the first self-replicating cell controlled entirely by a chemically synthesized genome, known as Synthia (Mycoplasma mycoides JCVI-syn1.0).
  4. The development of CRISPR-Cas9 gene editing technology in 2012 revolutionized synthetic biology by making precise genome editing faster, cheaper, and more accessible.
  5. Synthetic biology now enables applications such as engineered microbes that produce biofuels, pharmaceuticals like artemisinin, biodegradable plastics, and lab-grown meat.

Source

This History of Synthetic Biology timeline was generated with the help of AI, using information found on the internet.

We work hard to keep these timelines accurate, but mistakes do get through. If you spot one, email us at [email protected] and we'll fix it for future visitors.

Want a timeline like this one?

Generate yours with AI or build it from scratch, for free.

Try It for Free